News
Art Krieg was named CEO. Checkmate Pharmaceuticals came out of stealth mode this week with Art Krieg as its CEO, announcing that it had raised $20 million from Sofinnova Ventures and venBio and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback